Back
LOG IN / SIGN UP
Regular Income NBFC Bond
active
Secured
ISIN
INE140A07740
Investment Details
Key Terms
Minimum Investment
₹2,66,070.55
For Settlement Date Jul 13, 2026
Maturity Date
03 Nov 2026
3 Months 23 Days
Payment Frequency
annually
Coupon Rate
9.05 %
fixed
Financial Details
Coupon Type
fixed
Yield to maturity
7.96% p.a
Current Yield
9.03%
Clean Price
₹100.18
Dirty Price
₹106.43
Bond Details
Issue Size
N/A
Base Issue Size
N/A
Greenshoe Option Size
N/A
Issue Closes
N/A
Issue Type
nbfc
Face Value
₹1,000.00
Listed
Yes
Allotment Mode
N/A
Mode OF Issue
public placement
Settlement Date
Jul 13, 2026
Coupon Type
fixed
Call Date
N/A
Put Date
N/A
Tier
N/A
Perpetual
No
Issue Date
03 Nov 2023
Risk Factor
Tax Type
Taxable
Tax Free
Mode of Issue
Public
Private
Seniority
Non-Senior
Senior
Security
Unsecured
Secured
Issue Managers
Current MD/CEO
Ajay Piramal
Debenture Trustee
IDBI TRUSTEESHIP SERVICES LTD
Credit Rating
Cash Flow
Investment Amount
₹2,66,070.55
Settlement Date
Payment Term
annually
Units
250
Repayment Schedule
Download
Date
Interest (9.05%)
Principal
Nov 03, 2026
₹22,625.00
₹2,50,000.00
Net Returns
₹22,625.00
₹2,50,000.00
Documents
Start investing in Bonds
Debt Quality
Security
This bond is SECURED
Seniority
In case of default, the bond holders will be considered 'Senior' for payment
Listed
Listing details are not available
Issuer
Piramal Enterprises Limited
Issuer Overview
Piramal Enterprises Limited (PEL) is one of India’s leading diversified non-banking financial companies (NBFC) with assets worth ~$10 billion, with a network of over 400 branches across 26 states/Union Territories, offering a wide range of financial products and solutions across retail and wholesale lending, fund-based platforms and investments.
Issuer Highlights
- Piramal Enterprises Limited ('PEL') (Promoter – Mr. Ajay Piramal) is a non-deposit taking, RBI registered systemically important NBFC, engaged in providing wholesale and retail lending. Incorporated in Apr'47 it first entered the pharmaceuticals industry in '88.
- With an aim to segregate the businesses of the Piramal Group, PEL entered into scheme of arrangement with Piramal Pharma Limited ('PPL') & PHL Fininvest Private Limited ('PFPL') which was approved by the NCLT by way of its order dated August 12, 2022. Pursuant to this, pharmaceutical business was demerged from PEL, and wholly owned subsidiary PFPL was amalgamated into PEL.
Industry
Financial Services
Year Founded
1947
Sector
N/A
Ownership
N/A
Head Office
Mumbai
Similar Bonds
View More
Regular Income NBFC Bond
Min Investment
₹2,97,750.00
Payment
monthly
Yield to maturity
13.45%
Coupon Rate
10.40 %
Maturity Date
Nov 13, 2026
Rating
A(CRISIL)
Regular Income Corporate Bond
Min Investment
₹2,99,276.71
Payment
monthly
Yield to maturity
12.21%
Coupon Rate
10.50 %
Maturity Date
Jan 04, 2027
Rating
A(ICRA)
Regular Income Corporate Bond
Min Investment
₹3,04,654.52
Payment
quarterly
Yield to maturity
11.52%
Coupon Rate
10.40 %
Maturity Date
Apr 30, 2027
Rating
A(ICRA)
Close
Investment Calculator
250 units
Invested Amount
₹2,66,070.55
Earned Interest
₹22,625.00
Signup to Invest
Signup to Invest
Calculator